Stock PATH UIPATH INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News UiPath Inc.

Equities

PATH

US90364P1057

Real-time Estimate Cboe BZX
Other stock markets
 04:00:06 2024-04-29 pm EDT 		5-day change 1st Jan Change
19.84 USD +1.93% Intraday chart for UiPath Inc. +4.31% -20.67%
Apr. 09 Uipath Insider Sold Shares Worth $1,212,778, According to a Recent SEC Filing MT
Apr. 08 KeyBanc Assumes UiPath at Overweight, Sets $27 Price Target, Sees UiPath Well-Positioned to Keep Driving Market Share Gains MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Uipath Insider Sold Shares Worth $1,212,778, According to a Recent SEC Filing
MT
UiPath Named a Leader for Second Consecutive Year in the Everest Group Intelligent Document Processing (IDP) Products PEAK Matrix® Assessment 2024
BU
KeyBanc Assumes UiPath at Overweight, Sets $27 Price Target, Sees UiPath Well-Positioned to Keep Driving Market Share Gains
MT
UiPath Announces Sebastian Schrötel Joins Product Leadership Team to Lead UiPath Autopilot™ and Developer Experiences
BU
UiPath Appoints Sebastian Schrötel as Senior Vice President of Product Management
CI
UiPath : Announces Sebastian Schrötel Joins Product Leadership Team to Lead UiPath Autopilot™ and Developer Experiences
PU
UiPath Announces FedRAMP® Authorization for Its Automation Cloud™ Public Sector
BU
UiPath : Announces FedRAMP® Authorization for Its Automation Cloud™ Public Sector
PU
Canadian firm launches AI-powered ETF targeting AI investments
RE
Thinking about trading options or stock in Arm Holdings, UiPath, Dell Technologies, Digital World Acquisition, or Axsome Therapeutics?
PR
Romanian state agency turns to AI to help farmers tap EU funds
RE
UiPath Unveils New Family of LLMs at AI Summit to Empower Enterprises to Harness Full Capabilities of GenAI
BU
UiPath Unveils New Family of LLMs at AI Summit to Empower Enterprises to Harness Full Capabilities of GenAI
CI
Canaccord Genuity Raises Price Target on UiPath to $30 From $27, Maintains Buy Rating
MT
Macquarie Raises Price Target on UiPath to $29 From $28 Citing Balanced Growth/Margin, Strong Cash Flows, Cloud ARR Momentum, Keeps Outperform Rating
MT
Barclays Adjusts UiPath's Price Target to $25 From $23, Maintains Equalweight Rating
MT
North American Morning Briefing : Inflation -2-
DJ
TD Cowen Adjusts UiPath's Price Target to $28 From $25, Maintains Outperform Rating
MT
Evercore ISI Adjusts UiPath's Price Target to $27 From $24, Maintains In Line Rating
MT
UiPath's Outlook Clouded Despite Revenue and Profitability Gains, Morgan Stanley Says
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PATH Stock
  4. News UiPath Inc.